Case study: Optimize Manufacturability of a Cytotoxic ADC Through Process Development

Time: 2:30 pm
day: day 1 track 5 pm

Details:

• Leveraging process development
capabilities to avoid pitfalls
during technology transfer into
GMP assets
• Considerations on ADC
manufacturability illustrated by
a case study